244 related articles for article (PubMed ID: 7730726)
1. Changes in leprosy clinical pattern after multidrug therapy implementation.
Martelli CM; Andrade AL; Grossi MA; Leboeuf MA; Lombardi C; Zicker F
Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):95-7. PubMed ID: 7730726
[No Abstract] [Full Text] [Related]
2. Acute renal failure and multidrug therapy for leprosy.
Nishioka Sde A
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):259-60. PubMed ID: 9251601
[No Abstract] [Full Text] [Related]
3. Success of the WHO multidrug therapy?
Becx-Bleumink M
Trop Geogr Med; 1994; 46(2):61-4. PubMed ID: 8079392
[No Abstract] [Full Text] [Related]
4. Multidrug therapy in the control of leprosy. A field study.
Becx-Bleumink M
Trop Geogr Med; 1994; 46(2):109-14. PubMed ID: 8079385
[No Abstract] [Full Text] [Related]
5. A overview of ocular leprosy after 2 decades of multidrug therapy.
Lewallen S; Courtright P
Int Ophthalmol Clin; 2007; 47(3):87-101. PubMed ID: 17667278
[No Abstract] [Full Text] [Related]
6. [Leprosy control and multidrug therapy in Togo: problems and perspectives].
Edorh AA; Tignokpa N; David MT; Ihou E
Acta Leprol; 1992; 8(1):23-8. PubMed ID: 1523962
[TBL] [Abstract][Full Text] [Related]
7. Implementation of multidrug therapy for leprosy control programmes.
Porichha D
Lepr Rev; 1990 Dec; 61(4):392-3. PubMed ID: 2280664
[No Abstract] [Full Text] [Related]
8. Relapse rates following leprosy multidrug therapy.
Suite M
West Indian Med J; 2000 Sep; 49(3):210-1. PubMed ID: 11076211
[TBL] [Abstract][Full Text] [Related]
9. Five-year multiple drug therapy in Bendel State leprosy control service--an overview.
Majoroh TO
Afr J Med Med Sci; 1993 Sep; 22(3):29-33. PubMed ID: 7839909
[TBL] [Abstract][Full Text] [Related]
10. Reasons for interrupting multidrug therapy against leprosy: the patients' point of view.
Chichava OA; Ariza L; Oliveira AR; Ferreira AC; Da Silva LF; Barbosa AN; Ramos Júnior AN; Heukelbach J
Lepr Rev; 2011 Mar; 82(1):78-9. PubMed ID: 21644476
[No Abstract] [Full Text] [Related]
11. Regarding Brasil, et al.'s adverse effects in leprosy's WHO/MDT and paramedic's role in leprosy control program.
Cunha Mda G; Schettini AP; Pereira ES; Pedrosa VL; Cruz RC; Sadahiro M
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):257-9. PubMed ID: 9251600
[No Abstract] [Full Text] [Related]
12. Leprosy situation in Uttar Pradesh, 1991-2005: prevalence, case-detection and other indicators over a 15-year period.
Casabianca MN
Indian J Lepr; 2006; 78(2):137-43. PubMed ID: 16927848
[No Abstract] [Full Text] [Related]
13. A computer simulation of the effect of multidrug therapy on the incidence of leprosy.
Lechat MF; Misson CB; Vanderveken M; Vellut CM; Declercq EE
Ann Soc Belg Med Trop; 1987 Mar; 67(1):59-65. PubMed ID: 3632078
[No Abstract] [Full Text] [Related]
14. Leprosy and HIV co-infection in five patients.
Trindade MA; Manini MI; Masetti JH; Leite MA; Takahashi MD; Naafs B
Lepr Rev; 2005 Jun; 76(2):162-6. PubMed ID: 16038250
[TBL] [Abstract][Full Text] [Related]
15. Leprosy at a turning point?
Harboe M
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):312-8. PubMed ID: 11221095
[No Abstract] [Full Text] [Related]
16. Priorities for the future and prospects for leprosy control.
Becx-Bleumink M
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):82-101. PubMed ID: 8326185
[No Abstract] [Full Text] [Related]
17. Recent advances in the treatment of leprosy.
Ishii N
Dermatol Online J; 2003 Mar; 9(2):5. PubMed ID: 12639458
[TBL] [Abstract][Full Text] [Related]
18. Paucibacillary multidrug therapy in leprosy--7.5 years experience.
Reddy BN
Indian J Lepr; 1992; 64(4):546-7. PubMed ID: 1308534
[No Abstract] [Full Text] [Related]
19. Multidrug therapy in leprosy. WHO Study Group.
Nurs J India; 1984 Apr; 75(4):83-6, 90. PubMed ID: 6565263
[No Abstract] [Full Text] [Related]
20. New case-detection trends in a multi-drug therapy programme: definite reduction in sight.
Raja Rao B
Indian J Lepr; 2006; 78(2):123-36. PubMed ID: 16927847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
